What are the antibodies of hepatitis C?

The

antibodies of hepatitis C are a substance -based substance that the immune system produces in response to hepatitis C (HCV) infection. The antibodies recognize the virus in the body and try to destroy it. Hepatitis C antibodies can take several weeks to several months to detect through blood tests. Positive testing for antibodies does not mean that there is an active HCV infection. Further blood tests are required to confirm the presence of a living virus of hepatitis C.

Antibodies are immunoglobulins, which are proteins developed by the immune system in a direct response to specific antigen. Bacteria and viruses are classified as antigens. The antibody created has instead of a receptor at the tip of a protein that binds only with the exact antigen for which it was developed. The antibodies of hepatitis C are produced by plasma cells in the humoral immune system and are then excreted into the bloodstream.

Test for Hepatitis C antibodies may not be a useful diagnosisSticky tool for people who are immunocompromised because they do not develop antibodies because their immune system is not functional. If a person has a positive test result that shows hepatitis C antibodies, the doctor orders another blood test called HCV Ribonucleic acid test (RNA) to determine whether there is a chronic HCV infection. Most people have no symptoms during the acute phase of the disease. If the virus is still present in the body after six months, the infection is classified as chronic hepatitis C.

Chronic hepatitis virus C causes liver inflammation, which eventually may cause liver scarring. The finding or cirrhosis of the liver prevents the normal functioning of the organ. Increased levels of liver enzymes are common if the patient has hepatitis C. Most people with hepatitis C will develop only a mild form of infective has less liver damage. Overall liver failure is less common in HCV than in other forms of hepatitis.

Exposure of HCV virus will cause antibodies HEpatitis C, although there is no active infection. The most threatening HCV development is healthcare workers and people who use injection drugs and share contaminated syringes. Another high -risk category is people who need periodic blood transfusions such as haemophiliation and people with kidney disease.

The presence of hepatitis C antibodies does not mean hepatitis C immunity. The hepatitis C strains can be reactivated even after treatment destroys all active virus detected in the bloodstream. Hepatitis C antibodies will remain detectable for the rest of the person's life.